Pearl River Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,694
Closed -$2.03M 389
2024
Q2
$2.03M Buy
+18,694
New +$2.2M 0.32% 89
2024
Q1
Sell
-15,300
Closed -$1.86M 689
2023
Q4
$1.86M Sell
15,300
-15,054
-50% -$1.68M 0.3% 94
2023
Q3
$3.41M Buy
30,354
+15,176
+100% +$1.93M 0.53% 38
2023
Q2
$2.21M Sell
15,178
-2,243
-13% -$305K 0.36% 86
2023
Q1
$2.25M Buy
+17,421
New +$2.19M 0.36% 80
2022
Q1
Sell
-1,698
Closed -$209K 583
2021
Q4
$209K Buy
+1,698
New +$222K 0.06% 378
2021
Q3
Sell
-2,068
Closed -$323K 580
2021
Q2
$323K Sell
2,068
-3,449
-63% -$559K 0.09% 309
2021
Q1
$857K Buy
5,517
+734
+15% +$114K 0.27% 118
2020
Q4
$716K Buy
+4,783
New +$676K 0.26% 137
2020
Q3
Sell
-2,475
Closed -$287K 481
2020
Q2
$287K Buy
+2,475
New +$285K 0.14% 216
2020
Q1
Sell
-5,116
Closed -$743K 747
2019
Q4
$743K Buy
5,116
+4,905
+2,325% +$677K 0.28% 103
2019
Q3
$28K Sell
211
-914
-81% -$118K 0.08% 243
2019
Q2
$129K Buy
+1,125
New +$132K 0.82% 10

Other funds holding ZBH

Pearl River Capital's ZBH Position: Q3 2024 in Review

Pearl River Capital sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 18,694 shares — an estimated $2.03M sold.

Pearl River Capital first reported a position in ZBH in Q2 2019 and held it in 13 quarters. The position peaked at $3.41M in Q3 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Pearl River Capital reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Pearl River Capital sold 18,694 Zimmer Biomet shares in Q3 2024, an estimated $2.03M.
  • Pearl River Capital first reported a position in Zimmer Biomet in Q2 2019 and held it in 13 quarters.
  • Pearl River Capital's Zimmer Biomet position peaked at $3.41M in Q3 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.